Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:27 AM UTC
| NCT Number | NCT06297226 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 175 participants |
| Active Locations | 41 sites in the US |
| Sponsor | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company |
| Last Updated on CT.gov | February 10, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06297226 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 41 locations across the United States. The study is sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06297226 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 41 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06297226 was last updated 2 weeks ago (February 10, 2026). HelloStudys verifies this status automatically.